At the same time, all three drugs increase the frequency of hypertension, edema, renal disease and clinically important cardiovascular events, which seems similar in magnitude to that associated with NSAIDs.
Ces trois médicaments augmentent la fréquence de l'hypertension, de l'oedème, de maladies rénales et d'événements cardio-vasculaires importants sur le plan clinique, qui semblent similaires en magnitude à ceux associés aux AINS.